Back to the Top
I have heard that the FDA has approved labeling for a drug dose based on
simulations, even though that particular dose had not been tested in a
clinical trial. I would very much appreciate some details on this if
of you are familiar with the situation.
I think you might be referring to the NSAID from Syntex, Ketorolac. "AsBack to the Top
I recall, the approved dose was between two studied doses, not sure
what role simulation played. "Rather it was more like interpolation.
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (email@example.com)